- Home
- IVP vs BFRI Comparison
IVP vs BFRI Comparison
Compare IVP & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IVP
- BFRI
- Stock Information
- Founded
- IVP 2020
- BFRI 1997
- Country
- IVP United States
- BFRI United States
- Employees
- IVP N/A
- BFRI N/A
- Industry
- IVP Diversified Commercial Services
- BFRI Biotechnology: Pharmaceutical Preparations
- Sector
- IVP Miscellaneous
- BFRI Health Care
- Exchange
- IVP Nasdaq
- BFRI Nasdaq
- Market Cap
- IVP 7.3M
- BFRI 6.2M
- IPO Year
- IVP 2023
- BFRI 2021
- Fundamental
- Price
- IVP $0.19
- BFRI $0.97
- Analyst Decision
- IVP
- BFRI Strong Buy
- Analyst Count
- IVP 0
- BFRI 1
- Target Price
- IVP N/A
- BFRI $7.00
- AVG Volume (30 Days)
- IVP 1.5M
- BFRI 1.4M
- Earning Date
- IVP 11-13-2024
- BFRI 11-13-2024
- Dividend Yield
- IVP N/A
- BFRI N/A
- EPS Growth
- IVP N/A
- BFRI N/A
- EPS
- IVP N/A
- BFRI N/A
- Revenue
- IVP $17,054,777.00
- BFRI $35,358,000.00
- Revenue This Year
- IVP N/A
- BFRI $17.69
- Revenue Next Year
- IVP N/A
- BFRI $19.71
- P/E Ratio
- IVP N/A
- BFRI N/A
- Revenue Growth
- IVP 6.12
- BFRI 5.17
- 52 Week Low
- IVP $0.18
- BFRI $0.61
- 52 Week High
- IVP $50.00
- BFRI $4.00
- Technical
- Relative Strength Index (RSI)
- IVP 36.55
- BFRI 48.79
- Support Level
- IVP $0.20
- BFRI $0.94
- Resistance Level
- IVP $0.22
- BFRI $1.25
- Average True Range (ATR)
- IVP 0.02
- BFRI 0.14
- MACD
- IVP 0.01
- BFRI -0.00
- Stochastic Oscillator
- IVP 17.81
- BFRI 30.25
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.
About BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy (PDT) and topical antibiotics. Its licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. Its licensed product is Ameluz, which is a prescription drug approved for use in combination with the RhodoLED lamp series, for PDT (when used together, Ameluz PDT). including the complementary product BF-RhodoLED, and Xepi.